Data Science x Public Health

Resource allocation models are supposed to help public health systems distribute scarce resources more intelligently. They promise better targeting, more efficient deployment, and stronger impact under constraint. But what if the model is optimizing inside a system whose deepest constraints should never have been treated as fixed? In this episode, we break down why resource allocation models often...

Censoring is one of the most common assumptions in epidemiology and survival analysis. It is often treated as a routine technical step for handling people who leave observation before the study ends. But what if leaving the study is not random noise—and is actually part of the outcome process itself?  In this episode, we break down why censoring assumptions often fail, how loss to follow-up can di...

Model averaging is often presented as a more careful and uncertainty-aware alternative to choosing one model specification. It is supposed to reduce overconfidence and make analysis more robust. But what if all the models being averaged share the same blind spots from the start?  In this episode, we break down why model averaging often overpromises, how shared structural weaknesses survive the ave...

Real-time health alerts are supposed to detect danger faster and trigger earlier intervention. They promise speed, precision, and smarter public health response. But what if the alert is fast and the system behind it is still slow? In this episode, we break down why real-time health alerts often fail in practice, how organizational bottlenecks override detection speed, and why early warning only m...

Competing risks methods are often presented as a more realistic way to analyze time-to-event data in epidemiology and public health. They promise to handle situations where other events prevent the outcome of interest from ever occurring. But what if the method becomes more sophisticated while the interpretation becomes less clear?  In this episode, we break down why competing risks analyses are o...

External validation is often presented as the gold standard for proving that a predictive model works beyond its original dataset. It is supposed to show that the model can generalize to the real world. But what if one external dataset is still far too small a test of the outside world?  In this episode, we break down why external validation often overpromises, how “different” datasets can still b...

Public health scorecards are supposed to improve accountability and make system performance easier to track. They promise clarity, targets, and faster decision-making. But what if the scorecard starts changing behavior in the wrong direction? In this episode, we break down why public health scorecards often fail, how metrics become incentives, and why better-looking numbers can still hide weaker r...

Attack rates are one of the most common tools in outbreak epidemiology. They seem to offer a quick answer to a simple question: how many exposed people got sick? But what if the exposed group was never truly sharing the same exposure in the first place?  In this episode, we break down why attack rates often fail when exposure is uneven, how denominator assumptions distort outbreak interpretation,...

Adjustment for baseline differences is one of the most common moves in health research and biostatistics. It is often treated as proof that two groups have been made more comparable and that bias has been reduced. But what if that adjustment is creating more confidence than the data actually deserve?  In this episode, we break down why baseline adjustment often fails, how observed balance can hide...

AI triage tools are designed to identify high-risk patients and communities faster. They promise smarter prioritization, earlier intervention, and more efficient care delivery. But what if the model is not the real bottleneck at all? In this episode, we break down why AI triage tools often fail in real-world public health settings, how system constraints can cancel out model performance, and why p...

Secondary attack rates are often used to estimate how infection spreads among close contacts. They seem to provide a focused measure of transmission in households, schools, workplaces, and other settings. But what if the number is being shaped just as much by contact tracing and testing rules as by the pathogen itself?  In this episode, we break down why secondary attack rates often mislead, how i...

Sensitivity analyses are often presented as proof that a result is robust and trustworthy. They are supposed to show that findings hold up even when assumptions are changed. But what if the analysis only tested a tiny corner of the uncertainty that actually matters?  In this episode, we break down why sensitivity analyses often fail, how local robustness can create false reassurance, and why truly...

Health equity dashboards are supposed to make disparities visible and drive better public health decisions. They promise transparency, accountability, and measurable progress. But what if the dashboard is making inequity easier to display without making it easier to solve? In this episode, we break down why health equity dashboards often fail, how they can turn structural inequality into performan...

Prevalence is one of the most commonly used measures in epidemiology. It is often treated as a direct indicator of disease risk, spread, or public health urgency. But what if prevalence is telling a very different story than most people think?  In this episode, we break down what prevalence actually measures, why it is often confused with incidence and risk, and how that misunderstanding can disto...

Statistical power is one of the most familiar concepts in biostatistics and research design. It is supposed to help determine whether a study can detect a meaningful effect. But what if power is being used the wrong way after the study is already finished?  In this episode, we break down what statistical power actually means, why post hoc power language often misleads, and why large or “well-power...

We’re making a small but important update to the podcast schedule. To focus on delivering higher-quality, more in-depth content, we’re moving to a new release format: Triple-Drop Wednesdays. Starting next week, all three weekly episodes—covering data science in public health, epidemiology, and biostatistics—will be released together every Wednesday. This change allows for deeper insights while als...

Predictive models are widely used to identify high-risk patients and populations. They promise earlier intervention, better resource allocation, and improved outcomes. But what if prediction alone is not enough to actually change what happens next? In this episode, we break down the critical difference between prediction and causation—and why models that perform well statistically can still fail w...

Outbreak curves are one of the most recognizable tools in epidemiology. They appear to show whether an epidemic is rising, peaking, or falling in real time. But what if the curve is reflecting reporting behavior as much as disease transmission?  In this episode, we break down why outbreak curves often mislead, how reporting delays and revisions distort the shape people think they are seeing, and w...

Statistical significance is one of the most familiar ideas in research. It is often treated as the dividing line between real evidence and random noise. But what if that binary framing is doing more harm than good? In this episode, we break down why statistical significance often misleads, how threshold thinking distorts interpretation, and why effect size, uncertainty, and design quality matter f...

Health risk maps are one of the most persuasive tools in public health. They make danger visible, focus attention, and seem to show exactly where action is needed most. But what if the map is already out of date by the time anyone uses it? In this episode, we break down why health risk maps often fail when the data is delayed, how visual precision hides temporal weakness, and why public health dec...

Case fatality rate is one of the most commonly cited numbers during outbreaks and health emergencies. It seems to offer a direct answer to a simple question: how deadly is this disease? But what if the rate is being shaped less by biology and more by who gets detected as a case?  In this episode, we break down why case fatality rates often fail when detection is unequal, how testing and surveillan...

Subgroup analysis is one of the most persuasive tools in biostatistics and clinical research. It promises to show who benefits most, who responds differently, and where average effects break apart. But what if the study was never designed to answer those subgroup questions reliably?  In this episode, we break down why subgroup analysis so often misleads, how multiple testing and unstable estimates...

Benchmark accuracy is one of the most trusted signals in machine learning. It tells you which model performs best—and it often drives decisions about what gets deployed. But what if that number is giving you a false sense of confidence?  In this episode, we break down why models that perform well on benchmarks often fail in real-world settings. You will learn how dataset assumptions, evaluation me...

Incidence rates are one of the most common measures in epidemiology. They are used to describe how quickly disease is appearing in a population and to compare risk across groups. But what if the rate looks correct while the underlying time at risk is completely wrong?  In this episode, we break down why incidence rates fail when person-time is misdefined, how denominator errors distort epidemiolog...

Standard errors are one of the most overlooked pieces of statistical output. They sit underneath confidence intervals, p-values, and claims about precision in almost every study. But what if those standard errors are wrong from the start?  In this episode, we break down what standard errors actually represent, why they often fail when real-world data violate model assumptions, and how this creates...